HUMAN PAPILLOMAVIRUS-RELATED CERVICAL CARCINOMA
Clinical trials for HUMAN PAPILLOMAVIRUS-RELATED CERVICAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new HUMAN PAPILLOMAVIRUS-RELATED CERVICAL CARCINOMA trials appear
Sign up with your email to follow new studies for HUMAN PAPILLOMAVIRUS-RELATED CERVICAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
MRI-Guided radiation: a sharper aim for HPV cancers?
Disease control OngoingThis early-phase trial tests whether using MRI scans to guide the placement of internal radiation (brachytherapy) can improve treatment for women with advanced cervical or vaginal cancers linked to HPV. The study involves 26 participants and compares MRI-guided placement to stand…
Matched conditions: HUMAN PAPILLOMAVIRUS-RELATED CERVICAL CARCINOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
One shot to stop cancer: HPV vaccine study could change global prevention
Prevention OngoingThis study tests whether a single dose of the HPV vaccine can protect young women aged 18-30 from cervical cancer. Researchers in Costa Rica are giving 5,000 women either one HPV shot or a placebo to see if one dose is enough to prevent persistent HPV infections that can lead to …
Matched conditions: HUMAN PAPILLOMAVIRUS-RELATED CERVICAL CARCINOMA
Phase: PHASE4 • Sponsor: National Cancer Institute (NCI) • Aim: Prevention
Last updated Jul 02, 2026 00:00 UTC
-
At-Home style HPV test at Walk-In clinics could boost cancer screening
Prevention ENROLLING_BY_INVITATIONThis study tests whether offering women a simple self-collection kit for HPV testing at Express Care clinics (which have evening and weekend hours) increases cervical cancer screening rates. About 500 women aged 30–63 who are overdue for screening will either receive usual care o…
Matched conditions: HUMAN PAPILLOMAVIRUS-RELATED CERVICAL CARCINOMA
Phase: NA • Sponsor: Mayo Clinic • Aim: Prevention
Last updated Jun 27, 2026 13:04 UTC
-
One-Shot wonder? huge study tests single HPV vaccine dose
Prevention OngoingThis large study of nearly 28,000 girls aged 12-16 tests whether a single dose of HPV vaccine works as well as the standard two doses to prevent persistent infection with the virus types that cause most cervical cancers. If one dose is enough, it could lower costs and simplify va…
Matched conditions: HUMAN PAPILLOMAVIRUS-RELATED CERVICAL CARCINOMA
Phase: PHASE4 • Sponsor: National Cancer Institute (NCI) • Aim: Prevention
Last updated Jun 26, 2026 14:06 UTC
-
HPV Vaccine's Long-Term effects under the microscope in costa rica
Knowledge-focused OngoingThis study follows over 8,600 women in Costa Rica who received the HPV vaccine (types 16 and 18) years ago, plus unvaccinated controls, to see how well the vaccine protects over time. Researchers are checking for cervical lesions, immune markers, and any increase in infections fr…
Matched conditions: HUMAN PAPILLOMAVIRUS-RELATED CERVICAL CARCINOMA
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC